AlphaCentric Advisors »

Sanmina shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Sanmina (SANM) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Sanmina

Tip: Access up to 7 years of quarterly data

All positions including Sanmina held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sanmina by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $117k 464 253.08

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Vertex Pharmaceuticals Incorporated (VRTX)
Invitation Homes (INVH)
Astrazeneca Ord (AZN)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Axsome Therapeutics (AXSM)
Apogee Therapeutics (APGE)
Euronet Worldwide (EEFT)
Aeva Technologies Com New (AEVA)
Ishares Tr Rus 1000 Val Etf (IWD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for AlphaCentric Advisors

Top funds holding Sanmina

BlackRock
FMR
Vanguard Portfolio Management
Invesco
Vanguard Capital Management
Dimensional Fund Advisors
State Street Corporation
Geode Capital Management
Advanced Micro Devices
Bank of America Corporation
Morgan Stanley
Earnest Partners
Fisher Investments
Allianz Asset Management
Hanna Zanoni

View all funds holding Sanmina